Medicine and Dentistry
Antihypertensive Agent
7%
Blood
42%
Borderline Hypertension
7%
Combination Therapy
7%
Cyclosporine
14%
Drug Dose Reduction
7%
Drug Effect
7%
Drug Therapy
7%
Evaluation Study
7%
Fluorescence Polarization Immunoassay
7%
Hypertension
14%
Inpatient
28%
Lesion
7%
Measurement
14%
Monoclonal Antibody
7%
Observation
7%
Patient
100%
Psoriasis
28%
Recurrent Disease
7%
Relapse
7%
Side Effect
7%
Therapeutic Procedure
42%
Treatment Refusal
7%
Trough Level
28%
Nursing and Health Professions
Antihypertensive Agent
7%
Blood Level
35%
Borderline Hypertension
7%
Ciclosporin
14%
Combination Therapy
7%
Dose
28%
Drug Dose Reduction
7%
Drug Therapy
7%
Evaluation Study
7%
Fluorescence Polarization Immunoassay
7%
Hypertension
14%
Measurement
14%
Monoclonal Antibody
7%
Observation
7%
Procedures
7%
Psoriasis
28%
Recurrent Disease
7%
Relapse
7%
Side Effect
7%
Time
7%
Treatment Refusal
7%
Biochemistry, Genetics and Molecular Biology
Blood Level
35%
Cyclosporins
14%
Dose
28%
Drug Dose Reduction
7%
Drug Effect
7%
Fluorescence
7%
Monoclonal Antibody
7%
Polarization
7%
Reduction (Chemistry)
28%
Relapse
7%
Time
7%
Treatment Refusal
7%
Pharmacology, Toxicology and Pharmaceutical Science
Antihypertensive Agent
7%
Borderline Hypertension
7%
Ciclosporin
14%
Hypertension
14%
Monoclonal Antibody
7%
Psoriasis
28%
Recurrent Disease
7%
Relapse
7%
Side Effect
7%
Trough Level
28%